Development of molecularly targeted agents and immunotherapies in small cell lung cancer. (2016)
Attributed to:
BAG-1: A novel strategy for targeting the androgen receptor splice variants in castrate resistant prostate cancer.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ejca.2016.03.004
PubMed Identifier: 27060747
Publication URI: http://europepmc.org/abstract/MED/27060747
Type: Journal Article/Review
Volume: 60
Parent Publication: European journal of cancer (Oxford, England : 1990)
ISSN: 0959-8049